GE HealthCare to Acquire SOFIE Biosciences for $945 Million to Expand U.S. PET Radiopharmaceutical Supply
GE HealthCare has entered a definitive agreement to acquire SOFIE Biosciences, a U.S.-based PET radiopharmaceutical contract manufacturing organization, for $945 million in cash, establishing a “final mile” footprint for PET radiopharmaceutical supply and adding U.S. rights to the Phase III FAPI-74 radiotracer.
Read More